Literature DB >> 16472671

Nucleofection of primary neurons.

Annette Gärtner1, Ludovic Collin, Giovanna Lalli.   

Abstract

Efficient gene transfer is an important tool for the study of neuronal function and biology. This has proved difficult and inefficient with traditional transfection strategies, which can also be fairly toxic, whereas viral-mediated gene transfer, although highly efficient, is often time-consuming. The recently developed Amaxa Nucleofector technology, based on electroporation with preset parameters in a cell-type-specific solution, enables direct delivery of DNA, small interfering (si)RNA oligonucleotides and siRNA vectors into the cell nucleus. This strategy results in reproducible, rapid, and efficient transfection of a broad range of cells, including primary neurons. Nucleofected neurons survive for up to 3 weeks and remain functional. We are currently using this transfection method to examine the contribution of Rho GTPase signaling pathways in the establishment of neuronal polarity, neuronal migration, and neurite outgrowth. Here, we describe three protocols to efficiently nucleofect rat cerebellar granule, cortical, and hippocampal neurons.

Entities:  

Mesh:

Year:  2006        PMID: 16472671     DOI: 10.1016/S0076-6879(06)06027-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  21 in total

1.  Astrocytic responses to DNA delivery using nucleofection.

Authors:  H Muyderman; W P Yew; B Homkajorn; N R Sims
Journal:  Neurochem Res       Date:  2010-08-21       Impact factor: 3.996

2.  An efficient method for the long-term and specific expression of exogenous cDNAs in cultured Purkinje neurons.

Authors:  Wolfgang Wagner; Seumas McCroskery; John A Hammer
Journal:  J Neurosci Methods       Date:  2011-06-25       Impact factor: 2.390

3.  A method for stabilizing RNA for transfection that allows control of expression duration.

Authors:  Toshinori Hayashi; Deepak A Lamba; Amber Slowik; Thomas A Reh; Olivia Bermingham-McDonogh
Journal:  Dev Dyn       Date:  2010-07       Impact factor: 3.780

4.  Neuroprotective activity of leukemia inhibitory factor is relayed through myeloid zinc finger-1 in a rat model of stroke.

Authors:  Stephanie M Davis; Lisa A Collier; Elspeth A Foran; Christopher C Leonardo; Craig T Ajmo; Keith R Pennypacker
Journal:  Metab Brain Dis       Date:  2019-01-05       Impact factor: 3.584

5.  Serum inducible kinase is a positive regulator of cortical dendrite development and is required for BDNF-promoted dendritic arborization.

Authors:  Shun-Ling Guo; Guo-He Tan; Shuai Li; Xue-Wen Cheng; Ya Zhou; Yun-Fang Jia; Hui Xiong; Jiong Tao; Zhi-Qi Xiong
Journal:  Cell Res       Date:  2011-06-21       Impact factor: 25.617

6.  Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia.

Authors:  Bettina Thauerer; Stephanie zur Nedden; Gabriele Baier-Bitterlich
Journal:  J Neurochem       Date:  2010-01-28       Impact factor: 5.372

7.  High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA.

Authors:  Nada M Melhem; Sherrianne M Gleason; Xiang Dong Liu; Simon M Barratt-Boyes
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

8.  Functional protein delivery into neurons using polymeric nanoparticles.

Authors:  Linda Hasadsri; Jörg Kreuter; Hiroaki Hattori; Tadao Iwasaki; Julia M George
Journal:  J Biol Chem       Date:  2009-01-07       Impact factor: 5.157

9.  HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons.

Authors:  Stephanie zur Nedden; Bettina Tomaselli; Gabriele Baier-Bitterlich
Journal:  J Neurochem       Date:  2008-02-04       Impact factor: 5.372

10.  {alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics.

Authors:  Vítor L Sousa; Serena Bellani; Maila Giannandrea; Malikmohamed Yousuf; Flavia Valtorta; Jacopo Meldolesi; Evelina Chieregatti
Journal:  Mol Biol Cell       Date:  2009-06-24       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.